127 related articles for article (PubMed ID: 7853361)
1. Choline derivatives and sodium fluoride protect acetylcholinesterase against irreversible inhibition and aging by DFP and paraoxon.
Dehlawi MS; Eldefrawi AT; Eldefrawi ME; Anis NA; Valdes JJ
J Biochem Toxicol; 1994 Oct; 9(5):261-8. PubMed ID: 7853361
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):51-60. PubMed ID: 7737042
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of the in vitro inhibition, aging, and reactivation of brain acetylcholinesterase from rat and channel catfish by paraoxon and chlorpyrifos-oxon.
Carr RL; Chambers JE
Toxicol Appl Pharmacol; 1996 Aug; 139(2):365-73. PubMed ID: 8806854
[TBL] [Abstract][Full Text] [Related]
4. In vitro reactivation kinetics of paraoxon- and DFP-inhibited electric eel AChE using mono- and bis-pyridinium oximes.
Gupta B; Sharma R; Singh N; Kuca K; Acharya JR; Ghosh KK
Arch Toxicol; 2014 Feb; 88(2):381-90. PubMed ID: 24065055
[TBL] [Abstract][Full Text] [Related]
5. Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP.
Dettbarn WD; Yang ZP; Milatovic D
Chem Biol Interact; 1999 May; 119-120():445-54. PubMed ID: 10421482
[TBL] [Abstract][Full Text] [Related]
6. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
Funk KA; Liu CH; Higgins RJ; Wilson BW
Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human fetal brain acetylcholinesterase: marker effect of neurotoxicity.
Banerjee J; Ghosh P; Mitra S; Ghosh N; Bhattacharya S
J Toxicol Environ Health; 1991 Jul; 33(3):283-90. PubMed ID: 1906943
[TBL] [Abstract][Full Text] [Related]
8. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase fiber-optic biosensor for detection of anticholinesterases.
Rogers KR; Cao CJ; Valdes JJ; Eldefrawi AT; Eldefrawi ME
Fundam Appl Toxicol; 1991 May; 16(4):810-20. PubMed ID: 1909249
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of DFP- and paraoxon-inhibited acetylcholinesterases by pyridinium oximes.
Oh KA; Park NJ; Park NS; Kuca K; Jun D; Jung YS
Chem Biol Interact; 2008 Sep; 175(1-3):365-7. PubMed ID: 18565503
[TBL] [Abstract][Full Text] [Related]
11. Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro.
Ehrich M; Van Tassell R; Li Y; Zhou Z; Kepley CL
Toxicol In Vitro; 2011 Feb; 25(1):301-7. PubMed ID: 20888407
[TBL] [Abstract][Full Text] [Related]
12. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon.
Thiermann H; Eyer P; Worek F; Szinicz L
Toxicology; 2005 Oct; 214(3):190-7. PubMed ID: 16040183
[TBL] [Abstract][Full Text] [Related]
13. Comparison of inhibition kinetics of several organophosphates, including some nerve agent surrogates, using human erythrocyte and rat and mouse brain acetylcholinesterase.
Coban A; Carr RL; Chambers HW; Willeford KO; Chambers JE
Toxicol Lett; 2016 Apr; 248():39-45. PubMed ID: 26965078
[TBL] [Abstract][Full Text] [Related]
14. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
Galli A; Mori F; Gori I; Lucherini M
Biochem Pharmacol; 1992 Jun; 43(11):2427-33. PubMed ID: 1610407
[TBL] [Abstract][Full Text] [Related]
15. In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox).
Petroianu G; Arafat K; Kosanovic M; Saleh A; Camasamudram V; Hasan MY
J Appl Toxicol; 2003; 23(6):447-51. PubMed ID: 14635269
[TBL] [Abstract][Full Text] [Related]
16. Comparative sensitivity of bovine and rodent acetylcholinesterase to in vitro inhibition by organophosphate insecticides.
Cohen SD; Williams RA; Killinger JM; Freudenthal RI
Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):452-9. PubMed ID: 2417385
[TBL] [Abstract][Full Text] [Related]
17. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
Milatovic D; Dettbarn WD
Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
[TBL] [Abstract][Full Text] [Related]
18. Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
Wu CS; Yang JT
Mol Pharmacol; 1989 Jan; 35(1):85-92. PubMed ID: 2913485
[TBL] [Abstract][Full Text] [Related]
19. Reactivation and aging of phosphorylated brain acetylcholinesterase from fish and rodents.
Wallace KB; Herzberg U
Toxicol Appl Pharmacol; 1988 Feb; 92(2):307-14. PubMed ID: 3341039
[TBL] [Abstract][Full Text] [Related]
20. Absence of a protective effect of the oxime 2-PAM toward paraoxon-poisoned honey bees: acetylcholinesterase reactivation not at fault.
Polyzou A; Froment MT; Masson P; Belzunces LP
Toxicol Appl Pharmacol; 1998 Sep; 152(1):184-92. PubMed ID: 9772214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
